Clinical heterogeneity within chronic lymphocytic leukemia (CLL), especially in the majority of patients presenting with a low-tumour burden, provides a continuing impetus for the discovery of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback